Skip to main content

Table 4 Results on the various indicators and the summary outcome

From: Impact of a tailored program on the implementation of evidence-based recommendations for multimorbid patients with polypharmacy in primary care practices—results of a cluster-randomized controlled trial

Indicatora

Baseline T0

Follow-up T1

Treatment effect

p value

Control

Intervention

Control

Intervention

MEAN % (SD)

MEAN % (SD)

MEAN % (SD)

MEAN % (SD)

Estimate (95% CI)

1a

61.8 (27.6)

59.1 (28.6)

49.0 (30.0)

82.7 (20.4)

34.2 (12.4, 55.9)

0.017

1b

43.4 (36.0)

45.7 (37.8)

20.9 (20.9)

59.2 (33.9)

38.8 (15.0, 62.7)

0.012

2a

0 (0)

0.01 (0.02)

4.0 (7.5)

2.6 (6.3)

−3.4 (−8.0, 1.2)

0.18

2b

0 (0)

0.01 (0.02)

0 (0)

1.9 (5.6)

2.1 (−1.4, 5.5)

0.28

2c

1.4 (0.4)

1.7 (0.3)

48.4 (36.7)

25.0 (35.4)

−23.2 (−63.2, 16.8)

0.24

2d

27.4 (43.8)

25.6 (33.3)

31.2 (47.6)

8.2 (22.1)

−21.5 (−50.9, 8.0)

0.18

2e

70.9 (35.0)

55.3 (41.1)

93.9 (12.0)

92.7 (9.2)

0.1 (−9.2, 9.3)

0.99

3

10.9 (5.9)

13.7 (4.7)

20.8 (5.1)

14.5 (19.3)

−8.1 (−15.0, 1.2)

0.08

4a

25.0 (29.6)

15.0 (26.9)

20.5 (18.8)

22.5 (18.5)

5.6 (−5.6, 16.7)

0.35

4b

0 (0)

10.0 (24.2)

2.3 (7.5)

10.0 (21.1)

2.5 (−7.5, 12.4)

0.62

Primary outcome

24.1 (6.7)

22.8 (13.0)

27.9 (6.5)

31.5 (8.0)

4.2 (−0.3, 8.6)

0.10

  1. SD standard deviation
  2. aFor explanation of the indicators, see Table 1